Methylphenidate for Medical In-Patients
- 1 March 1986
- journal article
- case report
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 15 (1) , 75-79
- https://doi.org/10.2190/fnld-htdm-9lp1-x3y3
Abstract
Methylphenidate (Ritalin Hydrochloride) has been recommended as a treatment for depressed medical and geriatric patients. The rationale for this treatment includes both its safety (even in patients with contra-indications that prevent the use of other antidepressants) and its quick onset of action. In addition the drug can be withdrawn after a few weeks of treatment without the danger of a recurrence of depression. The author reports having used the drug safely in depressed medically ill patients with a success rate of at least 50 percent.Keywords
This publication has 11 references indexed in Scilit:
- Antidepressants and heart disease.BMJ, 1984
- Duration of Antidepressant Drug TreatmentArchives of General Psychiatry, 1984
- New antidepressantsComprehensive Psychiatry, 1983
- Use of psychostimulants in medically ill depressed patientsPsychosomatics, 1982
- Liaison psychiatry: referral patterns and their stability over timeAmerican Journal of Psychiatry, 1981
- Heterogeneity of amphetamine response in depressed patientsAmerican Journal of Psychiatry, 1981
- Treatment of depression in the medically ill elderly with methylphenidateAmerican Journal of Psychiatry, 1980
- Withdrawn, Apathetic Geriatric Patients Responsive to MethylphenidateJournal of the American Geriatrics Society, 1975
- Depression in Medical In-PatientsThe British Journal of Psychiatry, 1975
- Psychiatric Morbidity and Referral on Two General Medical WardsBMJ, 1974